The Medical Letter on Drugs and Therapeutics
FROM
ISSUE873
ISSUE873
June 26, 1992
Cefprozil
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Cefprozil
June 26, 1992 (Issue: 873)
Cefprozil (Cefzil - Bristol-Myers Squibb), a new oral second-generation cephalosporin, was recently released in the USA for treatment of pharyngitis, bronchitis, otitis media, and skin and skin-structure infections.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.